Global Pain Management Devices Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Devices (Electrical Stimulators, Neurostimulation Devices, Analgesic Infusion Pumps, Ablation Devices), By Applications (Facial & Migraine Pain, Neuropathic Pain, Cancer Pain, Musculoskeletal Pain, Others), And By Geography - Forecasts From 2022 To 2027

  • Published : Dec 2022
  • Report Code : KSI061611753
  • Pages : 116

The global pain management devices market is projected to witness a compounded annual growth rate of 12.32% to grow to US$10.427 billion by 2027, from US$4.625 billion in 2020.

Rising chronic diseases and the geriatric population are the key factors influencing the global pain management devices market. To manage pain, a precise combination of medicines or equipment is used. Pain management devices include transcutaneous electrical nerve triggers, neuro-triggers, the absence of pain mixture syphons, and radiofrequency ablators. A large portion of these devices blocks the pain entryway component, to impede the section of pain signs to the mind. Radiofrequency ablators obliterate nerves by creating warmth to impede the pain signals, Similarly, neuro-trigger devices utilize gentle frequencies of current to obstruct the entry of pain signals. These devices help in treating different painful conditions like malignant growth, musculoskeletal injury, and neuropathic pain. Pain management devices help to decrease the danger of long-haul opiates, non-steroidal calming drugs, and other pain-mitigating prescriptions.

The Centers for Disease Control and Prevention estimate that 50 million individuals in the United States suffer from chronic daily pain, with 19.6 million of those adults having high-impact chronic pain that interferes with their ability to go about their daily lives or their jobs. This is adding to the heal care burden of several countries. The market for pain management devices is appealing as technology, wearables, and gadgets become more integrated into customers' daily lives and consumer interest in these products shifts from novelty to more widely used pain management techniques.

Market Driver:

Growing geriatric population

People are living longer than ever before all throughout the world owing to better healthcare facilities and lesser wars. Longer lifespans correspond to a higher occurrence of pain, thus, there is an increasing need to prevent and reduce this discomfort. The ever-increasing number of people over the age of 65 is projected to contribute to the pain management devices market growth. According to the World Bank, in 2021, 9.54% of the population was above 65 years of age.

According to the United Nations (UN) statistics for World Population Prospects 2019, the world population is anticipated to rise by two billion people in the next 30 years, from 7.7 billion now to 9.7 billion in 2050, and the global elderly population is also rising. Due to rising life expectancy and declining fertility rates, the UN has stated that for the first time in history, people aged 65 and above outnumbered children under the age of five on a global scale. Furthermore, by 2050, one in every six persons in the globe will be over the age of 65 (16%), up from one in every eleven in 2019 (9%). Thus, due to the growth of the geriatric population and the incidence of arthritis among them, the need for pain management devices is projected to rise. 

Key development:

Omron added the new Focus TENS Therapy knee gadget to its current array of drug-free pain management devices in April 2020.  Over the forecast period, it is anticipated that the rising cancer cases will further increase demand.

COVID-19 impact on Pain Management Devices Market

The COVID-19 pandemic had a negative impact on the global pain management devices market in 2020. The COVID-19 virus may have a significant impact on patients with chronic pain as well as on the healthcare system. The CDC lists muscle pain as a frequent symptom of COVID-19 and quotes a World Health Organization study that found that 14.8% of patients had joint or muscle pain. The market was negatively impacted by the patients’ decreased access to pain management during the pandemic, and delays in treatments of chronic pain contributing to long-term health inequities with repercussions for recovery within healthcare systems due to attention being diverted to COVID-19 patients, social distancing measures, and lockdown. A majority of businesses have observed how the COVID-19 pandemic has affected their ability to manage staff and supply shortfalls as well as the availability of practitioners to prescribe products, and a slower ramping up of sales orders. For instance, in the fiscal year 2020, Boston Scientific Corporation's Neuromodulation business segment experienced a decline of 13% compared to 2019. Hence, there was a negative fallout for the pain management devices market in 2020.

Global Pain Management Devices Market Scope:


Report Metric Details
 Market Size Value in 2020  US$4.625 billion
 Market Size Value in 2027  US$10.427 billion
 Growth Rate  CAGR of 12.32% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Billion
 Segments Covered  Devices, Application, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered NeuroMetrix, Inc., Medtronic, Boston Scientific Corporation, Zynex Medical, BioElectronics Corporation, Pain Management Technologies, SPR Therapeutics, Becton, Dickinson, and Company, Abbott, Nevro Corp
 Customization Scope  Free report customization with purchase


Market Segmentation:

  • By Devices
    • Electrical Stimulators
    • Neurostimulation Devices
    • Analgesic Infusion Pumps
    • Ablation Devices
  • By Application
    • Facial & Migraine Pain
    • Neuropathic Pain
    • Cancer Pain
    • Musculoskeletal Pain
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • Italy
      • France
      • Others
    • Middle East and Africa
      • Israel
      • Saudi Arabia
      • Others
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

The global pain management devices market is projected to reach a total market size of US$10.427 billion in 2027.
The pain management devices market is projected to witness a CAGR of 12.32% over the forecast period.
Pain Management Devices Market was valued at US$4.625 billion in 2020.
Rising chronic diseases and the geriatric population are the key factors influencing the global pain management devices market.
The pain management devices market has been segmented by devices, application, and geography.


1.1. Market Overview

1.2. Covid-19 Scenario

1.3. Market Definition

1.4. Market Segmentation



2.1. Research Data

2.2. Assumptions



3.1. Research Highlights



4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.4. Industry Value Chain Analysis



5.1. Introduction 

5.2. Electrical Stimulators

5.3. Neurostimulation Devices

5.4. Analgesic Infusion Pumps

5.5. Ablation Devices



6.1. Introduction 

6.2. Facial & Migraine Pain

6.3. Neuropathic Pain

6.4. Cancer Pain

6.5. Musculoskeletal Pain

6.6. Others



7.1. Introduction 

7.2. North America

7.2.1. USA

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. UK

7.4.2. Germany

7.4.3. Italy

7.4.4. France

7.4.5. Others

7.5. Middle East and Africa

7.5.1. Israel

7.5.2. Saudi Arabia

7.5.3. Others

7.6. Asia Pacific

7.6.1. China

7.6.2. Japan

7.6.3. India

7.6.4. Australia

7.6.5. South Korea

7.6.6. Taiwan

7.6.7. Thailand

7.6.8. Indonesia

7.6.9. Others



8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix



9.1. NeuroMetrix, Inc.

9.2. Medtronic

9.3. Boston Scientific Corporation

9.4. Zynex Medical

9.5. BioElectronics Corporation

9.6. Pain Management Technologies

9.7. SPR Therapeutics

9.8. Becton, Dickinson, and Company

9.9. Abbott

9.10. Nevro Corp

NeuroMetrix, Inc.


Boston Scientific Corporation

Zynex Medical

BioElectronics Corporation

Pain Management Technologies

SPR Therapeutics

Becton, Dickinson, and Company


Nevro Corp